Rare diseases
Investigational molecules
Locations
Back to Spain3 330 clinical trials in Madrid, Spain across 24 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)A Study of INCB123667 in Patients With Platinum-Resistant Ovarian Cancer That Has High Levels of Cyclin E1 Protein
SpainStudy of icotrokinra for adults with moderately to severely active Crohn's disease
SpainTesting icotrokinra compared to placebo for adults and adolescents with moderately to severely active ulcerative colitis
SpainTesting zongertinib compared to standard treatment in patients with early-stage non-small cell lung cancer with HER2 mutations after surgery
SpainA Study of Evorpacept Combined with Trastuzumab and Chemotherapy for Patients with Metastatic HER2-Positive Breast Cancer
SpainStudy of melphalan followed by eribulin, vinorelbine, or capecitabine versus eribulin, vinorelbine, or capecitabine alone for metastatic breast cancer patients with liver disease
SpainA study testing VH4524184 with emtricitabine and tenofovir alafenamide compared to dolutegravir and lamivudine in adults with HIV-1 who have not received treatment before
SpainA Study of Amivantamab With Carboplatin and Pembrolizumab for Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
SpainA Study of Tulmimetostat and Luxdegalutamide Compared to Standard Treatment in Men with Advanced Prostate Cancer That No Longer Responds to Hormone Therapy
SpainA study testing tulmimetostat with darolutamide or abiraterone in patients with metastatic hormone-sensitive prostate cancer
SpainA study testing fitusiran to prevent bleeding in boys aged 1 to 11 years with hemophilia A or B with or without inhibitors
SpainA Study of Venetoclax in People with HIV-1 Infection Starting Antiretroviral Treatment to Reduce the HIV Reservoir
SpainThe busiest research cities in the country
What the registry says about research in the country
Investigating novel treatments for cutaneous lupus erythematosus and immune thrombocytopenia, with studies evaluating new therapeutic approaches to manage these challenging conditions.
Research focuses on improving treatment outcomes and quality of life for patients with autoimmune disorders.
Clinical trials examining innovative therapies for Type 1 Diabetes in combination with weight management, targeting both glycemic control and obesity-related complications.
Studies aim to develop comprehensive treatment approaches for complex metabolic conditions.
Breakthrough research in multiple sclerosis and acute ischemic stroke, exploring new therapeutic options for both pediatric and adult populations.
Focus on developing targeted treatments to improve neurological outcomes and patient care.
Comprehensive vaccine studies targeting respiratory syncytial virus, influenza, and herpes zoster, with particular attention to vulnerable populations.
Research aims to enhance protection against common and serious infectious diseases.
Innovative studies in mantle cell lymphoma and bladder cancer, exploring combination therapies and targeted treatments to improve patient outcomes.
Focus on developing more effective and personalized cancer treatments.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
